2011
DOI: 10.1016/j.jalz.2011.05.001
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of cognition in early dementia

Abstract: Better tools for assessing cognitive impairment in the early stages of Alzheimer’s disease (AD) are required to enable diagnosis of the disease before substantial neurodegeneration has taken place and to allow detection of subtle changes in the early stages of progression of the disease. The National Institute on Aging and the Alzheimer’s Association convened a meeting to discuss state of the art methods for cognitive assessment, including computerized batteries, as well as new approaches in the pipeline. Spea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
76
1
4

Year Published

2015
2015
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 81 publications
(82 citation statements)
references
References 117 publications
1
76
1
4
Order By: Relevance
“…[38] Moreover, computer-based virtual reality tests may be difficult for older adults to perform, especially those with cognitive impairment. [8, 39] Logistical considerations limited the size of the maze and inclusion of walls in the design. However, it may not be practical in many clinical and research settings to erect large scale mazes with walls.…”
Section: Discussionmentioning
confidence: 99%
“…[38] Moreover, computer-based virtual reality tests may be difficult for older adults to perform, especially those with cognitive impairment. [8, 39] Logistical considerations limited the size of the maze and inclusion of walls in the design. However, it may not be practical in many clinical and research settings to erect large scale mazes with walls.…”
Section: Discussionmentioning
confidence: 99%
“…It is not clear, however, that biological markers alone will be able to effectively identify these at-risk individuals given the presence of AD pathology in a large number of cognitively healthy elderly [4,5]. Furthermore, while cognitive probes could provide a more widely applicable and cost effective method of identification, traditional cognitive assessment instruments may not be effective at detecting subtle cognitive changes associated with the earliest stages of the disease [6]. A novel and potentially more fruitful approach would be to exploit recent advances in cognitive neuroscience to develop cognitive measures that more directly reflect the pathology present in the earliest stages of AD.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, many researchers studying Alzheimer's disease (AD) have concluded that intervention and assessment of cognitive impairment in the early stage of AD likely need to be started before neurodegeneration has destroyed substantial regions of the brain (Silverberg et al, 2011). Mild cognitive impairment (MCI) has emerged as a classification that defines the transitional state from normal cognitive function to dementia, with an elevated risk of progression to AD (i.e., conversion; Matthews et al, 2008;Roberts & Knopman, 2013), In addition, MCI has been investigated in clinical trials (Cabral, Morgado, Campos Costa, Silveira, & Alzheimers Disease Neuroimaging Initiative, 2015;Gauthier et al, 2006).…”
mentioning
confidence: 99%